Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bill Could Jeopardize State Coverage Mandates For Screening, Diabetes

This article was originally published in The Gray Sheet

Executive Summary

Legislation designed to cut health benefit costs for small employers could limit patient access to cancer screening services and diabetes equipment, some device firms and patient advocacy groups contend

You may also be interested in...



Senate vote defeats S.1955

The Senate votes against moving forward with the "Health Insurance Marketplace Modernization and Affordability Act" (S. 1955), on May 11. The bill, introduced by committee Chair Mike Enzi (R-Wyo.) would have cut health benefit costs for small employers. Opponents argued that small business employees would lose important healthcare benefits such as screenings for several cancers, well-child care and immunizations, maternity care, mental health coverage and diabetes supplies and education (1"The Gray Sheet" March 27, 2006, p. 19)...

Senate vote defeats S.1955

The Senate votes against moving forward with the "Health Insurance Marketplace Modernization and Affordability Act" (S. 1955), on May 11. The bill, introduced by committee Chair Mike Enzi (R-Wyo.) would have cut health benefit costs for small employers. Opponents argued that small business employees would lose important healthcare benefits such as screenings for several cancers, well-child care and immunizations, maternity care, mental health coverage and diabetes supplies and education (1"The Gray Sheet" March 27, 2006, p. 19)...

State Clinical Trial Coverage, Screening Laws Endangered By AHP Bill – Blues

Small business health plan legislation circulating on Capitol Hill would undermine state laws benefiting device companies, BlueCross BlueShield Federal Relations Director Justine Handelman warned May 19

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel